Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A three-year randomized placebo-controlled trial. Have a read: https://www.m3india.in/contents/journal/intralymphatic-immunotherapy-improves-grass-pollen-allergic-rhinoconjunctivitis-a-three-year-randomized?utm_campaign=unset&utm_medium=share&utm_source=ref_wa